Philogen Reports Full Year 2021 Results and Provides Corporate Update Patient enrolment in Nidlegy™’s European Phase III trial for the…
CAMBRIDGE, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company using translational bioinformatics to advance…
Company announcement no. 4 - 221 April 2022 Reporting of transactions made by persons discharging managerial responsibilities and persons closely…
COPENHAGEN, Denmark, April 1, 2022 – In accordance with the Company’s remuneration policy, the Board of Directors of Bavarian…
KODEX-EPD cardiac imaging and mapping system from Philips Philips KODEX-EPD cryoballoon procedure Philips GlideLight Laser Sheath for lead management Philips…
Press release (MAR)Malmö, Sweden, April 1, 2022 FDA requests supplementary information for Acarix breakthrough designation request for heart failure diagnosis The Food and…
April 1, 2022Announcement no. 6 Managers’ transactions In connection with the completion of BioPorto A/S’ rights issue as described in…
EUROAPI listing on Euronext Paris expected on May 6, 2022 French AMF approved EUROAPI’s listing prospectus EUROAPI first day of…
TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven…
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2022 after…